Loading data for PEN — first visit, this takes a few seconds.
Penumbra Inc. (PEN)
NYSE: PEN
· Real-Time Price · USD
323.75
-1.43 (-0.44%)
At close: Aug 25, 2026, 8:00 PM
324.37
+0.00%
After-hours: 7:51 PM
The price, the headline numbers and the latest news, in one place.
Penumbra Inc. (PEN) Stock Price, Analysis & Data
-0.44% (1D)
No data available
| Bid | n/a |
| Market Cap | 12.78B |
| Revenue (ttm) | 1.5B |
| Net Income (ttm) | 160.59M |
| 0.70 | |
| 4.09 | |
| 79.31 | |
| 52.9 | |
| P/B (ttm) | 8.35 |
| P/S (ttm) | 8.49 |
| Earnings Date | Nov 4, 2026 |
| Ask | n/a |
| Volume | 144,266 |
| Avg. Volume (20D) | 365,830 |
| Open | 324.91 |
| Previous Close | 325.18 |
| Day's Range | 323.44 - 324.69 |
| 52-Week Range | 221.26 - 362.41 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About PEN
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access prod...
Industry Medical Devices
Sector Healthcare
IPO Date Sep 18, 2015
Employees 4,700
Stock Exchange NYSE
Ticker Symbol PEN
Website https://www.penumbrainc.com
Financial Performance
In 2025, Penumbra's revenue was 1.4B, an increase of 17.5% compared to the previous year's 1.19B. Earnings were 177.69M, an increase of 1,168.11%.
Financial StatementsEarnings Surprise
Penumbra has released their quarterly earnings on Jul 30, 2026:
- Revenue of $390.05M misses estimates by $0, with 14.90% YoY growth.
- EPS of 1.01 misses estimates by -0.17, with 17.44% YoY growth.
Penumbra Inc. is scheduled to release its earnings on Nov 4, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2